Logos Global Management
$2.3B 13F equity value
89 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Logos Global Management covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| ERAS | ERASCA INC | 12,150,000 | $223M | 9.6% |
| ABVX | ABIVAX SA | 1,024,000 | $136M | 5.9% |
| RVMD | REVOLUTION MEDICINES INC | 700,000 | $131M | 5.6% |
| IDYA | IDEAYA BIOSCIENCES INC | 3,000,000 | $112M | 4.8% |
| BNTX | BIONTECH SE | 1,015,000 | $94M | 4.1% |
| VERA | VERA THERAPEUTICS INC | 2,200,000 | $94M | 4.1% |
| TNGX | TANGO THERAPEUTICS INC | 2,850,000 | $89M | 3.8% |
| PRAX | PRAXIS PRECISION MEDICINES I | 260,000 | $87M | 3.7% |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 2,100,000 | $78M | 3.4% |
| DNTH | DIANTHUS THERAPEUTICS INC | 800,000 | $78M | 3.4% |
Track Logos Global Management's 13F portfolio: $2.3B in reported holdings, 89 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}